Laboratory Corp of America Holdings (LH)
198.65
-1.32
(-0.66%)
USD |
NYSE |
Apr 18, 13:27
Laboratory Corp of America Holdings Enterprise Value: 21.35B for April 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 17, 2024 | 21.35B |
April 16, 2024 | 21.52B |
April 15, 2024 | 21.63B |
April 12, 2024 | 21.84B |
April 11, 2024 | 21.90B |
April 10, 2024 | 21.96B |
April 09, 2024 | 22.20B |
April 08, 2024 | 22.20B |
April 05, 2024 | 22.30B |
April 04, 2024 | 22.30B |
April 03, 2024 | 22.38B |
April 02, 2024 | 22.36B |
April 01, 2024 | 22.73B |
March 28, 2024 | 22.91B |
March 27, 2024 | 22.75B |
March 26, 2024 | 22.49B |
March 25, 2024 | 22.51B |
March 22, 2024 | 22.47B |
March 21, 2024 | 22.30B |
March 20, 2024 | 22.14B |
March 19, 2024 | 22.28B |
March 18, 2024 | 22.16B |
March 15, 2024 | 22.13B |
March 14, 2024 | 22.11B |
March 13, 2024 | 22.68B |
Date | Value |
---|---|
March 12, 2024 | 22.77B |
March 11, 2024 | 22.91B |
March 08, 2024 | 22.82B |
March 07, 2024 | 22.90B |
March 06, 2024 | 22.85B |
March 05, 2024 | 22.71B |
March 04, 2024 | 22.96B |
March 01, 2024 | 22.87B |
February 29, 2024 | 22.68B |
February 28, 2024 | 22.60B |
February 27, 2024 | 22.67B |
February 26, 2024 | 22.65B |
February 23, 2024 | 22.96B |
February 22, 2024 | 22.80B |
February 21, 2024 | 22.82B |
February 20, 2024 | 22.63B |
February 16, 2024 | 22.71B |
February 15, 2024 | 23.17B |
February 14, 2024 | 23.67B |
February 13, 2024 | 23.27B |
February 12, 2024 | 23.62B |
February 09, 2024 | 23.21B |
February 08, 2024 | 23.23B |
February 07, 2024 | 23.30B |
February 06, 2024 | 23.18B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.02B
Minimum
Mar 23 2020
33.37B
Maximum
Dec 30 2021
25.26B
Average
24.49B
Median
Enterprise Value Benchmarks
Quest Diagnostics Inc | 18.32B |
Exact Sciences Corp | 13.07B |
Natera Inc | 10.39B |
Delcath Systems Inc | 91.41M |
Progyny Inc | 2.789B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -167.10M |
Revenue (Quarterly) | 3.033B |
Total Expenses (Quarterly) | 2.804B |
EPS Diluted (Quarterly) | -1.97 |
Gross Profit Margin (Quarterly) | 27.08% |
Profit Margin (Quarterly) | -5.51% |
Earnings Yield | 2.34% |
Operating Earnings Yield | 6.52% |
Normalized Earnings Yield | 3.781 |